FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014083259> ?p ?o ?g. }

• W2014083259 endingPage "1128" @default.
• W2014083259 startingPage "1119" @default.
• W2014083259 abstract "The structure of the infectious form of prion protein, PrPSc, remains unclear. Most pure recombinant prion protein (PrP) amyloids generated in vitro are not infectious and lack the extent of the protease-resistant core and solvent exclusion of infectious PrPSc, especially within residues ∼90–160. Polyanionic cofactors can enhance infectivity and PrPSc-like characteristics of such fibrils, but the mechanism of this enhancement is unknown. In considering structural models of PrPSc multimers, we identified an obstacle to tight packing that might be overcome with polyanionic cofactors, namely, electrostatic repulsion between four closely spaced cationic lysines within a central lysine cluster of residues 101–110. For example, in our parallel in-register intermolecular β-sheet model of PrPSc, not only would these lysines be clustered within the 101–110 region of the primary sequence, but they would have intermolecular spacings of only ∼4.8 Å between stacked β-strands. We have now performed molecular dynamics simulations predicting that neutralization of the charges on these lysine residues would allow more stable parallel in-register packing in this region. We also show empirically that substitution of these clustered lysine residues with alanines or asparagines results in recombinant PrP amyloid fibrils with extended proteinase-K resistant β-sheet cores and infrared spectra that are more reminiscent of bona fide PrPSc. These findings indicate that charge neutralization at the central lysine cluster is critical for the folding and tight packing of N-proximal residues within PrP amyloid fibrils. This charge neutralization may be a key aspect of the mechanism by which anionic cofactors promote PrPSc formation.Key factors modulating conversion of prion protein into prions remain unclear.ResultsNeutralization of a cluster of lysines within residues 101–110 promoted formation of an N-terminally extended recombinant prion protein amyloid core.ConclusionA central lysine cluster strongly modulates folding of prion protein amyloids.SignificanceThese findings highlight a key structural factor in the PrPSc-like folding of prion protein. The structure of the infectious form of prion protein, PrPSc, remains unclear. Most pure recombinant prion protein (PrP) amyloids generated in vitro are not infectious and lack the extent of the protease-resistant core and solvent exclusion of infectious PrPSc, especially within residues ∼90–160. Polyanionic cofactors can enhance infectivity and PrPSc-like characteristics of such fibrils, but the mechanism of this enhancement is unknown. In considering structural models of PrPSc multimers, we identified an obstacle to tight packing that might be overcome with polyanionic cofactors, namely, electrostatic repulsion between four closely spaced cationic lysines within a central lysine cluster of residues 101–110. For example, in our parallel in-register intermolecular β-sheet model of PrPSc, not only would these lysines be clustered within the 101–110 region of the primary sequence, but they would have intermolecular spacings of only ∼4.8 Å between stacked β-strands. We have now performed molecular dynamics simulations predicting that neutralization of the charges on these lysine residues would allow more stable parallel in-register packing in this region. We also show empirically that substitution of these clustered lysine residues with alanines or asparagines results in recombinant PrP amyloid fibrils with extended proteinase-K resistant β-sheet cores and infrared spectra that are more reminiscent of bona fide PrPSc. These findings indicate that charge neutralization at the central lysine cluster is critical for the folding and tight packing of N-proximal residues within PrP amyloid fibrils. This charge neutralization may be a key aspect of the mechanism by which anionic cofactors promote PrPSc formation.Key factors modulating conversion of prion protein into prions remain unclear. Neutralization of a cluster of lysines within residues 101–110 promoted formation of an N-terminally extended recombinant prion protein amyloid core. A central lysine cluster strongly modulates folding of prion protein amyloids." @default.
• W2014083259 created "2016-06-24" @default.
• W2014083259 creator A5010714838 @default.
• W2014083259 creator A5010907811 @default.
• W2014083259 creator A5011828447 @default.
• W2014083259 creator A5015110041 @default.
• W2014083259 creator A5042945741 @default.
• W2014083259 creator A5057284942 @default.
• W2014083259 creator A5089718148 @default.
• W2014083259 date "2015-01-01" @default.
• W2014083259 modified "2023-09-30" @default.
• W2014083259 title "Charge Neutralization of the Central Lysine Cluster in Prion Protein (PrP) Promotes PrPSc-like Folding of Recombinant PrP Amyloids" @default.
• W2014083259 cites W1504267511 @default.
• W2014083259 cites W1557182452 @default.
• W2014083259 cites W1566848521 @default.
• W2014083259 cites W1567267284 @default.
• W2014083259 cites W1584074575 @default.
• W2014083259 cites W1765055414 @default.
• W2014083259 cites W1784563469 @default.
• W2014083259 cites W1938969372 @default.
• W2014083259 cites W1963550622 @default.
• W2014083259 cites W1973758214 @default.
• W2014083259 cites W1980075338 @default.
• W2014083259 cites W1986735189 @default.
• W2014083259 cites W1988707129 @default.
• W2014083259 cites W1990623935 @default.
• W2014083259 cites W1991424179 @default.
• W2014083259 cites W1997973599 @default.
• W2014083259 cites W2002013853 @default.
• W2014083259 cites W2003156002 @default.
• W2014083259 cites W2003676486 @default.
• W2014083259 cites W2003869458 @default.
• W2014083259 cites W2008789887 @default.
• W2014083259 cites W2014742609 @default.
• W2014083259 cites W2015329538 @default.
• W2014083259 cites W2020707497 @default.
• W2014083259 cites W2022392367 @default.
• W2014083259 cites W2022614447 @default.
• W2014083259 cites W2024290067 @default.
• W2014083259 cites W2025658533 @default.
• W2014083259 cites W2033917233 @default.
• W2014083259 cites W2040375783 @default.
• W2014083259 cites W2041250499 @default.
• W2014083259 cites W2048881833 @default.
• W2014083259 cites W2050407137 @default.
• W2014083259 cites W2051677555 @default.
• W2014083259 cites W2056426612 @default.
• W2014083259 cites W2057293794 @default.
• W2014083259 cites W2064367582 @default.
• W2014083259 cites W2067540111 @default.
• W2014083259 cites W2070878385 @default.
• W2014083259 cites W2072303997 @default.
• W2014083259 cites W2077657292 @default.
• W2014083259 cites W2084646890 @default.
• W2014083259 cites W2084863049 @default.
• W2014083259 cites W2090184114 @default.
• W2014083259 cites W2098949341 @default.
• W2014083259 cites W2106246537 @default.
• W2014083259 cites W2110420813 @default.
• W2014083259 cites W2118966800 @default.
• W2014083259 cites W2120671345 @default.
• W2014083259 cites W2132346258 @default.
• W2014083259 cites W2138390885 @default.
• W2014083259 cites W2150891508 @default.
• W2014083259 cites W2153896793 @default.
• W2014083259 cites W2154010286 @default.
• W2014083259 cites W2154493095 @default.
• W2014083259 cites W2162615082 @default.
• W2014083259 cites W2169849112 @default.
• W2014083259 doi "https://doi.org/10.1074/jbc.m114.619627" @default.
• W2014083259 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4294479" @default.
• W2014083259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25416779" @default.
• W2014083259 hasPublicationYear "2015" @default.
• W2014083259 type Work @default.
• W2014083259 sameAs 2014083259 @default.
• W2014083259 citedByCount "39" @default.
• W2014083259 countsByYear W20140832592015 @default.
• W2014083259 countsByYear W20140832592016 @default.
• W2014083259 countsByYear W20140832592017 @default.
• W2014083259 countsByYear W20140832592018 @default.
• W2014083259 countsByYear W20140832592019 @default.
• W2014083259 countsByYear W20140832592020 @default.
• W2014083259 countsByYear W20140832592021 @default.
• W2014083259 countsByYear W20140832592022 @default.
• W2014083259 countsByYear W20140832592023 @default.
• W2014083259 crossrefType "journal-article" @default.
• W2014083259 hasAuthorship W2014083259A5010714838 @default.
• W2014083259 hasAuthorship W2014083259A5010907811 @default.
• W2014083259 hasAuthorship W2014083259A5011828447 @default.
• W2014083259 hasAuthorship W2014083259A5015110041 @default.
• W2014083259 hasAuthorship W2014083259A5042945741 @default.
• W2014083259 hasAuthorship W2014083259A5057284942 @default.
• W2014083259 hasAuthorship W2014083259A5089718148 @default.
• W2014083259 hasBestOaLocation W20140832591 @default.
• W2014083259 hasConcept C104317684 @default.
• W2014083259 hasConcept C119599485 @default.
• W2014083259 hasConcept C12554922 @default.
• W2014083259 hasConcept C127413603 @default.

• next